Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Home-based Exercise in Chronic Kidney Disease (HBCKD-BCN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03621176
Recruitment Status : Completed
First Posted : August 8, 2018
Last Update Posted : February 27, 2019
Sponsor:
Collaborator:
Consorci Sanitari de Terrassa. Hospital de Terrassa
Information provided by (Responsible Party):
Eva Segura Ortí, Cardenal Herrera University

Brief Summary:
A home-based exercise program will be implemented in three different groups of participants: advanced chronic kidney disease, end-stage renal disease in substitutive treatment hemodialysis or peritoneal dialysis. Participants will be evaluated before the program, after 3 months and after 6 months from the starting of the program. During the first 3 months the researcher will phone them weekly to reinforce the exercise habit, and during the last three months, there will be no reinforcement. Assessment will include strength, functional capacity, health-related quality of life and depressive symptoms.

Condition or disease Intervention/treatment Phase
Chronic Kidney Disease End-stage Renal Disease Other: Home-based exercise Not Applicable

Detailed Description:

Three groups of participants (advanced chronic disease not yet in substitutive treatment, end-stage renal disease patients in hemodialysis and end-stage renal disease patients in peritoneal dialysis) will enter the study. The intervention will consist of a home-based exercise program. They will be provided with a booklet and the researcher will explain personally each of the exercises to the participants. Progression will be encouraged so that the participants should find the sessions 'somewhat hard' according to the rate of perceived exertion. Reinforcement will be high during the first 3 months (weekly phone calls, visits to the nephrology department) and none during the last 3 months. Assessment will be undertaken at three-time points: baseline, after 3 months of high reinforcement and after 3 more months of no reinforcement at all.

Assessment will include strength, functional capacity, health-related quality of life, cognitive state and depressive symptoms.

The aim of the study is to assess the effectiveness of home-based exercise to improve strength, physical function, health-related quality of life, cognitive state and depressive symptoms in advanced chronic kidney disease and end-stage renal disease (hemodialysis and peritoneal dialysis). We also aim at describing all these variables in the three different groups of patients. Adherence and satisfaction with the exercise program will be recorded at the end of the study.

Additionally, interobserver reliability will be calculated, so as reliability intraobserver in different measurement conditions (dialysis vs non-dialysis days).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 57 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: All participants will undertake the exercise intervention. We will compare effects of the intervention between different cohorts included (advanced chronic kidney disease, end-stage renal disease hemodialysis o peritoneal dialysis)
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of Home-based Exercise in Advanced Chronic Kidney Disease and End-stage Renal Disease
Actual Study Start Date : August 1, 2018
Actual Primary Completion Date : January 31, 2019
Actual Study Completion Date : February 14, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Home-based exercise
Home-based intervention in the advanced chronic kidney disease group, hemodialysis or peritoneal dialysis group
Other: Home-based exercise
A booklet with detailed information will be provided, and the exercises will be previously reviewed with every patient by the researcher. Participants will be encouraged to perform at least 3 sessions per week and monitor their heart rate. They will be instructed that the exercises should be perceived as 'somewhat hard' from a rate of perceived exertion. Adaptations to increase the intensity of the exercises will be provided so that participants can progress in exercise intensity




Primary Outcome Measures :
  1. Change from baseline sit to stand 10 test at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    Sit to stand to sit test 10, time to perform 10 repetitions


Secondary Outcome Measures :
  1. Change from baseline Six-minute walking test at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    Distance covered in 6 minutes

  2. Change from baseline STS-60 at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    Sit to stand to sit test 60, number of repetitions performed during 60 seconds

  3. Change from baseline OLHR at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    One leg heel rise test, number of repetitions of heel rise to measure triceps strength

  4. Change from baseline Handgrip strength (dynamometry) at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    Handgrip strength measured through a dynamometer

  5. Change from baseline SPPB at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    Short physical performance battery, a combination of walking speed, STS-5 and balance

  6. Change from baseline OLST at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    One-leg stand test, time to keep the balance in one leg

  7. Change from baseline TUG at 12 and 24 weeks [ Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks ]
    Timed up and go test, time to stand up from a chair, walk 3m, turn around and sit back again

  8. Change from baseline Albumin at 12 and 24 weeks [ Time Frame: Baseline,12 weeks, 24 weeks ]
    Serum albumin in blood for dialysis patients

  9. Change from baseline Health-related quality of life measured through the Euro quality of life questionnaire, 5 dimensions, at 12 and 24 weeks [ Time Frame: Baseline,12 weeks, 24 weeks ]
    Euroquol 5D questionnaire, scale 0 (worst health) to 100 (best health). 5 Dimensions include mobility, personal care, activities of daily living, pain, and anxiety/depression

  10. Change from baseline Beck depression inventory at 12 and 24 weeks [ Time Frame: Baseline,12 weeks, 24 weeks ]
    Questionnaire to measure depressive symptoms. Range from 0 (normal) to 63 (worst depression)

  11. Change from baseline Human activity profile at 12 and 24 weeks Human activity profile [ Time Frame: Baseline,12 weeks, 24 weeks ]
    Questionnaire to measure physical activity. Higher score represents higher activity. Measures of average and maximal activity scores are reported. Average activity scores bellow 53 are considered impaired; between 53 and 74 are considered moderately active and above 74 are considered active.

  12. Change from baseline Physical Activity Scale for the elderly at 12 and 24 weeks [ Time Frame: Baseline,12 weeks, 24 weeks ]
    Questionnaire to measure physical activity. Higher scores represent higher activity.

  13. Adherence [ Time Frame: 12 weeks, 24 weeks ]
    Sessions performed/offered x 100



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • At least 3 months in hemodialysis treatment
  • Clinically stable

Exclusion Criteria:

  • Recent cardiac events (less than 3 months)
  • Unable to exercise

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03621176


Locations
Layout table for location information
Spain
Hospital de Terrassa
Terrassa, Barcelona, Spain, 08227
Sponsors and Collaborators
Cardenal Herrera University
Consorci Sanitari de Terrassa. Hospital de Terrassa
Investigators
Layout table for investigator information
Study Chair: Vicent Esteve-Simó, PhD Hospital de Terrassa
Publications:
Layout table for additonal information
Responsible Party: Eva Segura Ortí, Professor, Cardenal Herrera University
ClinicalTrials.gov Identifier: NCT03621176    
Other Study ID Numbers: HBCKD
First Posted: August 8, 2018    Key Record Dates
Last Update Posted: February 27, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Eva Segura Ortí, Cardenal Herrera University:
Exercise
Health-related quality of life
Physical function
Hemodialysis
Peritoneal dialysis
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency